Connexin43 mimetic peptide is neuroprotective and improves function following spinal cord injury

Neuroscience Research

Volumn 75, Issue 3, 2013, Pages 256-267

  O'Carroll, Simon J ^a   Gorrie, Catherine A ^b,c   Velamoor, Sailakshmi ^a   Green, Colin R ^a   Nicholson, Louise F B ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Connexin; Cytokines; Mimetic peptide; Neuroinflammation; Neuroprotection; Spinal cord injury

Indexed keywords

CARPROFEN; CEFALOTIN; CONNEXIN 43; PEPTIDE DERIVATIVE; PEPTIDE5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; GLIOSIS; HINDLIMB; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MICROGLIA; MOTONEURON; NEUROPROTECTION; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SPINAL CORD INJURY; TISSUE SECTION; WESTERN BLOTTING;

ANIMALS; BEHAVIOR, ANIMAL; CONNEXIN 43; INFUSION PUMPS; INJECTIONS, SPINAL; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; THORACIC VERTEBRAE;

EID: 84875956067     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2013.01.004     Document Type: Article

References (84)

1. Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable Locomotor Rating Scale for open field testing in rats. J. Neurotrauma 1995, 12:1-21.
2. Berthoud V.M., Beyer E.C., Seul K.H. Peptide inhibitors of intercellular communication. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L619-L622.
3. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., Loor K., Green J., Dietrich W.D. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 1999, 16:851-863.
4. Boitano S., Evans W.H. Connexin mimetic peptides reversibly inhibit Ca(2+) signaling through gap junctions in airway cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L623-L630.
5. Braet K., Aspeslagh S., Vandamme W., Willecke K., Martin P.E., Evans W.H., Leybaert L. Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells. J. Cell. Physiol. 2003, 197:205-213.
6. Brambilla R., Bracchi-Ricard V., Hu W.H., Frydel B., Bramwell A., Karmally S., Green E.J., Bethea J.R. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 2005, 202:145-156.
7. Budd S.L., Lipton S.A. Calcium tsunamis: do astrocytes transmit cell death messages via gap junctions during ischemia?. Nat. Neurosci. 1998, 1:431-432.
8. Bush T.G., Puvanachandra N., Horner C.H., Polito A., Ostenfeld T., Svendsen C.N., Mucke L., Johnson M.H., Sofroniew M.V. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999, 23:297-308.
9. Carriedo S.G., Yin H.Z., Weiss J.H. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci. 1996, 16:4069-4079.
10. Chanson M., Derouette J.P., Roth I., Foglia B., Scerri I., Dudez T., Kwak B.R. Gap junctional communication in tissue inflammation and repair. Biochim. Biophys. Acta 2005, 1711:197-207.
11. Contreras J.E., Saez J.C., Bukauskas F.F., Bennett M.V. Gating and regulation of connexin43 (Cx43) hemichannels. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:11388-11393.
12. Contreras J.E., Sanchez H.A., Eugenin E.A., Speidel D., Theis M., Willecke K., Bukauskas F.F., Bennett M.V., Saez J.C. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:495-500.
13. Contreras J.E., Sanchez H.A., Veliz L.P., Bukauskas F.F., Bennett M.V., Saez J.C. Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res. Brain Res. Rev. 2004, 47:290-303.
14. Cronin M., Anderson P.N., Cook J.E., Green C.R., Becker D.L. Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. Mol. Cell. Neurosci. 2008, 39:152-160.
15. Danesh-Meyer H.V., Kerr N.M., Zhang J., Eady E.K., O'Carroll S.J., Nicholson L.F., Johnson C.S., Green C.R. Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia. Brain 2012, 135:506-520.
16. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., Littman D.R., Dustin M.L., Gan W.B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8:752-758.
17. Davidson J.O., Green C.R., Nicholson L.F., O'Carroll S.J., Fraser M., Bennet L., Gunn A.J. Connexin hemichannel blockade improves outcomes in a model of fetal ischemia. Ann. Neurol. 2012, 71:121-132.
18. De Vuyst E., Decrock E., De Bock M., Yamasaki H., Naus C.C., Evans W.H., Leybaert L. Connexin hemichannels and gap junction channels are differentially influenced by lipopolysaccharide and basic fibroblast growth factor. Mol. Biol. Cell 2007, 18:34-46.
19. Donnelly D.J., Popovich P.G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol. 2008, 209:378-388.
20. Dusart I., Schwab M.E. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur. J. Neurosci. 1994, 6:712-724.
21. Esen N., Shuffield D., Syed M.M., Kielian T. Modulation of connexin expression and gap junction communication in astrocytes by the gram-positive bacterium S. aureus. Glia 2007, 55:104-117.
22. Eugenin E.A., Eckardt D., Theis M., Willecke K., Bennett M.V., Saez J.C. Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon-gamma and tumor necrosis factor-alpha. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:4190-4195.
23. Faigle M., Seessle J., Zug S., El Kasmi K.C., Eltzschig H.K. ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS ONE 2008, 3:e2801.
24. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 2004, 24:2143-2155.
25. Fitch M.T., Doller C., Combs C.K., Landreth G.E., Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 1999, 19:8182-8198.
26. Fonseca C.G., Green C.R., Nicholson L.F. Upregulation in astrocytic connexin 43 gap junction levels may exacerbate generalized seizures in mesial temporal lobe epilepsy. Brain Res. 2002, 929:105-116.
27. Frantseva M.V., Kokarovtseva L., Naus C.G., Carlen P.L., MacFabe D., Perez Velazquez J.L. Specific gap junctions enhance the neuronal vulnerability to brain traumatic injury. J. Neurosci. 2002, 22:644-653.
28. Frantseva M.V., Kokarovtseva L., Perez Velazquez J.L. Ischemia-induced brain damage depends on specific gap-junctional coupling. J. Cereb. Blood Flow Metab. 2002, 22:453-462.
29. Garg S., Md Syed M., Kielian T. Staphylococcus aureus-derived peptidoglycan induces Cx43 expression and functional gap junction intercellular communication in microglia. J. Neurochem. 2005, 95:475-483.
30. Genovese T., Mazzon E., Crisafulli C., Di Paola R., Muia C., Bramanti P., Cuzzocrea S. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J. Pharmacol. Exp. Ther. 2006, 316:1006-1016.
31. Giaume C., Kirchhoff F., Matute C., Reichenbach A., Verkhratsky A. Glia: the fulcrum of brain diseases. Cell Death Differ. 2007, 14:1324-1335.
32. Gorrie C.A., Hayward I., Cameron N., Kailainathan G., Nandapalan N., Sutharsan R., Wang J., Mackay-Sim A., Waite P.M. Effects of human OEC-derived cell transplants in rodent spinal cord contusion injury. Brain Res. 2010, 1337:8-20.
33. Green C.R., Law L.-Y., Lin J.S., Becker D.L. Spatiotemporal depletion of connexins using antisense oligonucleotides. Methods in Molecular Biology: Connexin Methods and Protocols 2001, 175-185. Humana Press Inc., Totawa, NJ. R. Bruzzone, C. Giaume (Eds.).
34. Haghikia A., Ladage K., Lafenetre P., Hinkerohe D., Smikalla D., Haase C.G., Dermietzel R., Faustmann P.M. Intracellular application of TNF-alpha impairs cell to cell communication via gap junctions in glioma cells. J. Neurooncol. 2008, 86:143-152.
35. Haupt C., Witte O.W., Frahm C. Up-regulation of Connexin43 in the glial scar following photothrombotic ischemic injury. Mol. Cell. Neurosci. 2007, 35:89-99.
36. Hausmann O.N. Post-traumatic inflammation following spinal cord injury. Spinal Cord 2003, 41:369-378.
37. Hawat G., Benderdour M., Rousseau G., Baroudi G. Connexin 43 mimetic peptide Gap26 confers protection to intact heart against myocardial ischemia injury. Pflugers Arch. 2010, 460:583-592.
38. Horn K.P., Busch S.A., Hawthorne A.L., van Rooijen N., Silver J. Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J. Neurosci. 2008, 28:9330-9341.
39. Huang C., Han X., Li X., Lam E., Peng W., Lou N., Torres A., Yang M., Garre J.M., Tian G.F., Bennett M.V., Nedergaard M., Takano T. Critical role of connexin 43 in secondary expansion of traumatic spinal cord injury. J. Neurosci. 2012, 32:3333-3338.
40. John G.R., Scemes E., Suadicani S.O., Liu J.S., Charles P.C., Lee S.C., Spray D.C., Brosnan C.F. IL-1beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:11613-11618.
41. John S.A., Kondo R., Wang S.Y., Goldhaber J.I., Weiss J.N. Connexin-43 hemichannels opened by metabolic inhibition. J. Biol. Chem. 1999, 274:236-240.
42. Kang J., Kang N., Lovatt D., Torres A., Zhao Z., Lin J., Nedergaard M. Connexin 43 hemichannels are permeable to ATP. J. Neurosci. 2008, 28:4702-4711.
43. Kielian T. Glial connexins and gap junctions in CNS inflammation and disease. J. Neurochem. 2008, 106:1000-1016.
44. Klusman I., Schwab M.E. Effects of pro-inflammatory cytokines in experimental spinal cord injury. Brain Res. 1997, 762:173-184.
45. Kondo R.P., Wang S.Y., John S.A., Weiss J.N., Goldhaber J.I. Metabolic inhibition activates a non-selective current through connexin hemichannels in isolated ventricular myocytes. J. Mol. Cell. Cardiol. 2000, 32:1859-1872.
46. Koshinaga M., Whittemore S.R. The temporal and spatial activation of microglia in fiber tracts undergoing anterograde and retrograde degeneration following spinal cord lesion. J. Neurotrauma 1995, 12:209-222.
47. Kwak B.R., Jongsma H.J. Selective inhibition of gap junction channel activity by synthetic peptides. J. Physiol. 1999, 516(Pt 3):679-685.
48. Lee I.H., Lindqvist E., Kiehn O., Widenfalk J., Olson L. Glial and neuronal connexin expression patterns in the rat spinal cord during development and following injury. J. Comp. Neurol. 2005, 489:1-10.
49. Leybaert L., Braet K., Vandamme W., Cabooter L., Martin P.E., Evans W.H. Connexin channels, connexin mimetic peptides and ATP release. Cell Commun. Adhes. 2003, 10:251-257.
50. Loane D.J., Byrnes K.R. Role of microglia in neurotrauma. Neurotherapeutics 2010, 7:366-377.
51. Martin P.E., Wall C., Griffith T.M. Effects of connexin-mimetic peptides on gap junction functionality and connexin expression in cultured vascular cells. Br. J. Pharmacol. 2005, 144:617-627.
52. Morita M., Saruta C., Kozuka N., Okubo Y., Itakura M., Takahashi M., Kudo Y. Dual regulation of astrocyte gap junction hemichannels by growth factors and a pro-inflammatory cytokine via the mitogen-activated protein kinase cascade. Glia 2007, 55:508-515.
53. Mulcahy N.J., Ross J., Rothwell N.J., Loddick S.A. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br. J. Pharmacol. 2003, 140:471-476.
54. Myer D.J., Gurkoff G.G., Lee S.M., Hovda D.A., Sofroniew M.V. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 2006, 129:2761-2772.
55. Nakase T., Sohl G., Theis M., Willecke K., Naus C.C. Increased apoptosis and inflammation after focal brain ischemia in mice lacking connexin43 in astrocytes. Am. J. Pathol. 2004, 164:2067-2075.
56. Naus C.C., Bechberger J.F., Caveney S., Wilson J.X. Expression of gap junction genes in astrocytes and C6 glioma cells. Neurosci. Lett. 1991, 126:33-36.
57. Norenberg M.D., Smith J., Marcillo A. The pathology of human spinal cord injury: defining the problems. J. Neurotrauma 2004, 21:429-440.
58. O'Carroll S.J., Alkadhi M., Nicholson L.F., Green C.R. Connexin 43 mimetic peptides reduce swelling, astrogliosis, and neuronal cell death after spinal cord injury. Cell Commun. Adhes. 2008, 15:27-42.
59. Oguro K., Jover T., Tanaka H., Lin Y., Kojima T., Oguro N., Grooms S.Y., Bennett M.V., Zukin R.S. Global ischemia-induced increases in the gap junctional proteins connexin 32 (Cx32) and Cx36 in hippocampus and nhanced vulnerability of Cx32 knock-out mice. J. Neurosci. 2001, 21:7534-7542.
60. Ohsumi A., Nawashiro H., Otani N., Ooigawa H., Toyooka T., Shima K. Temporal and spatial profile of phosphorylated connexin43 after traumatic brain injury in rats. J. Neurotrauma 2010, 27:1255-1263.
61. Okada S., Nakamura M., Katoh H., Miyao T., Shimazaki T., Ishii K., Yamane J., Yoshimura A., Iwamoto Y., Toyama Y., Okano H. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat. Med. 2006, 12:829-834.
62. Orellana J.A., Froger N., Ezan P., Jiang J.X., Bennett M.V., Naus C.C., Giaume C., Saez J.C. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J. Neurochem. 2011, 118:826-840.
63. Orellana J.A., Hernandez D.E., Ezan P., Velarde V., Bennett M.V., Giaume C., Saez J.C. Hypoxia in high glucose followed by reoxygenation in normal glucose reduces the viability of cortical astrocytes through increased permeability of connexin 43 hemichannels. Glia 2010, 58:329-343.
64. Orellana J.A., Saez P.J., Shoji K.F., Schalper K.A., Palacios-Prado N., Velarde V., Giaume C., Bennett M.V., Saez J.C. Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. Antioxid. Redox Signal. 2009, 11:369-399.
65. Orellana J.A., Shoji K.F., Abudara V., Ezan P., Amigou E., Saez P.J., Jiang J.X., Naus C.C., Saez J.C., Giaume C. Amyloid beta-induced death in neurons involves glial and neuronal hemichannels. J. Neurosci. 2011, 31:4962-4977.
66. Popovich P.G., Guan Z., McGaughy V., Fisher L., Hickey W.F., Basso D.M. The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J. Neuropathol. Exp. Neurol. 2002, 61:623-633.
67. Qiu C., Coutinho P., Frank S., Franke S., Law L.Y., Martin P., Green C.R., Becker D.L. Targeting connexin43 expression accelerates the rate of wound repair. Curr. Biol. 2003, 13:1697-1703.
68. Renault-Mihara F., Okada S., Shibata S., Nakamura M., Toyama Y., Okano H. Spinal cord injury: emerging beneficial role of reactive astrocytes' migration. Int. J. Biochem. Cell Biol. 2008, 40:1649-1653.
69. Retamal M.A., Cortes C.J., Reuss L., Bennett M.V., Saez J.C. S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: induction by oxidant stress and reversal by reducing agents. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:4475-4480.
70. Retamal M.A., Froger N., Palacios-Prado N., Ezan P., Saez P.J., Saez J.C., Giaume C. Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J. Neurosci. 2007, 27:13781-13792.
71. Scemes E., Suadicani S.O., Dahl G., Spray D.C. Connexin and pannexin mediated cell-cell communication. Neuron Glia Biol. 2007, 3:199-208.
72. Shaikh S.B., Uy B., Perera A., Nicholson L.F. AGEs-RAGE mediated up-regulation of connexin43 in activated human microglial CHME-5 cells. Neurochem. Int. 2012, 60:640-651.
73. Shechter R., London A., Varol C., Raposo C., Cusimano M., Yovel G., Rolls A., Mack M., Pluchino S., Martino G., Jung S., Schwartz M. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 2009, 6:e1000113.
74. Siushansian R., Bechberger J.F., Cechetto D.F., Hachinski V.C., Naus C.C. Connexin43 null mutation increases infarct size after stroke. J. Comp. Neurol. 2001, 440:387-394.
75. Takahashi D.K., Vargas J.R., Wilcox K.S. Increased coupling and altered glutamate transport currents in astrocytes following kainic-acid-induced status epilepticus. Neurobiol. Dis. 2010, 40:573-585.
76. Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., Sonobe Y., Mizuno T., Suzumura A. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 2006, 281:21362-21368.
77. Theriault E., Frankenstein U.N., Hertzberg E.L., Nagy J.I. Connexin43 and astrocytic gap junctions in the rat spinal cord after acute compression injury. J. Comp. Neurol. 1997, 382:199-214.
78. Tsang Y.M., Chiong F., Kuznetsov D., Kasarskis E., Geula C. Motor neurons are rich in non-phosphorylated neurofilaments: cross-species comparison and alterations in ALS. Brain Res. 2000, 861:45-58.
79. Vis J.C., Nicholson L.F., Faull R.L., Evans W.H., Severs N.J., Green C.R. Connexin expression in Huntington's diseased human brain. Cell Biol. Int. 1998, 22:837-847.
80. Yan P., Li Q., Kim G.M., Xu J., Hsu C.Y., Xu X.M. Cellular localization of tumor necrosis factor-alpha following acute spinal cord injury in adult rats. J. Neurotrauma 2001, 18:563-568.
81. Yang L., Blumbergs P.C., Jones N.R., Manavis J., Sarvestani G.T., Ghabriel M.N. Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury. Spine 2004, 29:966-971.
82. Yang L., Jones N.R., Blumbergs P.C., Van Den Heuvel C., Moore E.J., Manavis J., Sarvestani G.T., Ghabriel M.N. Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J. Clin. Neurosci. 2005, 12:276-284.
83. Ye Z.C., Wyeth M.S., Baltan-Tekkok S., Ransom B.R. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J. Neurosci. 2003, 23:3588-3596.
84. Yoon J.J., Green C.R., O'Carroll S.J., Nicholson L.F. Dose-dependent protective effect of connexin43 mimetic peptide against neurodegeneration in an ex vivo model of epileptiform lesion. Epilepsy Res. 2010, 92:153-162.